Key result
Pharmacologic and nonpharmacologic strategies successfully treat hypertension and reduce associated morbidity and mortality in elderly populations.
Why the study?
Do pharmacologic and nonpharmacologic strategies reduce morbidity and mortality in elderly patients with hypertension?
Do pharmacologic and nonpharmacologic strategies reduce morbidity and mortality in elderly patients with hypertension?
Pharmacologic and nonpharmacologic treatments for hypertension in the elderly are effective, well-tolerated, and reduce morbidity and mortality.
Answers are grounded in this paper and cite their sources.
Supports tolerated hypertension strategies in elderly; leaves open optimal contemporary regimens pending updated trials.
Much of the developed world’s population is aging. Hypertension is a common condition that increases steadily with age and is most prevalent in the elderly. In the last two decades, a number of clinical trials have increased the awareness of the consequences of hypertension and enhanced the understanding of its treatment. Both pharmacologic and nonpharmacologic strategies have been found to be successful in treating hypertension and reducing the frequency of associated morbidity and mortality in the elderly. Moreover, these treatments appear to be well tolerated and feasible to implement in geriatric populations. It is incumbent upon healthcare providers and policymakers alike to diligently pursue judicious management of hypertension in older patients.
No takes yet. Share an insight, caveat, or question.
Michael J. Fischer (2009) conducted a review in Hypertension. Pharmacologic and nonpharmacologic strategies was evaluated. Pharmacologic and nonpharmacologic strategies successfully treat hypertension and reduce associated morbidity and mortality in elderly populations.
Synapse has enriched 10 related papers. Consider them for comparative context: